Bio Pharma Dive

SEPTEMBER 9, 2022

David Kaslow, the lead scientist at a global public health nonprofit, will succeed Marion Gruber, who retired last fall amid her dissent on the timing of COVID-19 vaccine boosters.

Vaccination 265

Vaccination Vaccine Scientist 265

BioSpace

NOVEMBER 10, 2021

?Scientists are conducting research into the possibility of creating a vaccine that activates T cells that targets not just SARS-CoV-2 but also its variations, even the ones that cause common colds.

Scientist 110

Scientist Vaccination Vaccine Research 110

Medical Xpress

NOVEMBER 18, 2022

Rutgers scientists have developed a new approach to stopping viral infections: a so-called live-attenuated, replication-defective DNA virus vaccine that uses a compound known as centanamycin to generate an altered virus for vaccine development.

DNA 91

DNA Scientist Vaccination Vaccine 91

Scienmag

JUNE 9, 2022

HAMILTON, June 10, 2022–McMaster University scientists who compared respiratory vaccine-delivery systems have confirmed that inhaled aerosol vaccines provide far better protection and stronger immunity than nasal sprays.

Scientist 97

Scientist Vaccination Vaccine 97

Bio Pharma Dive

FEBRUARY 24, 2021

Agency scientists noted the shot's strong protection against severe COVID-19, even for the virus variant first detected in South Africa and known to weaken vaccine potency.

Vaccination 321

Vaccination Vaccine Scientist 321

XTalks

FEBRUARY 15, 2024

In the life sciences, countless Black scientists, researchers and medical professionals have made groundbreaking discoveries that have significantly advanced our understanding of biology and medicine. They serve as inspiration for future generations of scientists from all backgrounds.

Life Science 115

Life Science Scientist Protein Research 115

XTalks

DECEMBER 13, 2023

This episode features an interview with vaccine scientists and executives from Vaccines Global Clinical Development at Merck, Dr. Heather Platt, MD, Distinguished Scientist and Pneumococcal Vaccine Lead; and Dr. Ulrike Buchwald, MD, Scientific Associate Vice President, Global Clinical Research and Pneumococcal Vaccine Section Head.

Life Science 52

Life Science Vaccination Vaccine Scientist 52

Medical Xpress

JANUARY 4, 2023

Scientists are harnessing a new way to turn cancer cells into potent, anti-cancer agents. The team tested their dual-action, cancer-killing vaccine in an advanced mouse model of the deadly brain cancer glioblastoma, with promising results. In the latest work from the lab of Khalid Shah, MS, Ph.D.,

Scientist 98

Scientist Vaccination Vaccine Development 98

Bio Pharma Dive

DECEMBER 15, 2020

A review by agency staff affirmed the strongly positive results Moderna reported from a large Phase 3 study, clearing the way for a possible emergency authorization in the coming days.

Scientist 315

Scientist Vaccination Vaccine 315

Bio Pharma Dive

AUGUST 11, 2020

The shot, developed by the state-backed Gamaleya Research Institute, hasn't yet been tested in the large, placebo-controlled tests scientists emphasize are needed to prove a vaccine is protective.

Vaccination 272

Vaccination Vaccine Scientist Development 272

pharmaphorum

JANUARY 8, 2021

The Pfizer/BioNTech vaccine appears to work against an important mutation in the new coronavirus variants causing havoc in the UK and South Africa, according to research from the drugs giant. The study team tested blood taken from people who had received the mRNA vaccine developed by BioNTech and Pfizer.

Scientist 123

Scientist Vaccination Vaccine Immune Response 123

Scienmag

MAY 31, 2022

LA JOLLA, CA—Scientists at La Jolla Institute for Immunology (LJI) have published the first analysis of how four types of COVID-19 vaccines prepare the body to fight SARS-CoV-2.

Scientist 79

Scientist Vaccination Vaccine Antibody 79

STAT News

JANUARY 23, 2023

Scientists at the Food and Drug Administration propose making Covid vaccination a regular, once-a-year shot that is updated to match current strains of the SARS-CoV-2 virus, according to documents posted by the FDA on Monday. For people who are older or immunocompromised, the FDA would recommend two annual doses of the revised shot.

Scientist 139

Scientist Vaccination Vaccine Drugs 139

Pharmaceutical Technology

DECEMBER 7, 2022

BioPIPS plans to utilise research and innovation to enhance the biologics manufacturing expertise of Singapore, which comprises recombinant therapeutic proteins and vaccines. The solutions created through BioPIPS will also boost the country’s capacity for meeting the rising demand for biologics and vaccines throughout the world.

Scientist 130

Scientist Manufacturing Vaccination Vaccine 130

XTalks

FEBRUARY 12, 2024

The ad pays homage to notable scientists throughout the times and also celebrates 175 years of Pfizer’s contributions to scientific innovation. In the commercial, Pfizer highlighted some of its major scientific offerings throughout the centuries, which include contributions to the mass production of penicillin and creating COVID-19 vaccines.

Scientist 105

Scientist DNA Vaccination Vaccine 105

Scienmag

DECEMBER 1, 2021

An international team of scientists believe they may have found a molecular mechanism behind the extremely rare blood clots linked to adenovirus COVID-19 vaccines.

Scientist 87

Scientist Vaccination Vaccine Medicine 87

NY Times

SEPTEMBER 13, 2020

Researchers say drug companies need to be more open about how vaccine trials are run to reassure Americans who are skittish about getting a coronavirus vaccine.

Vaccination 140

Vaccination Vaccine Scientist Trials 140

BioSpace

MARCH 17, 2021

According to an interview with Soumya Swaminathan, the WHO's chief scientist, the new investigational COVID-19 vaccines rely on alternative technologies and systems of delivery. Some include oral and nasal administration, while others use skin patches.

Scientist 99

Scientist Vaccination Vaccine Research 99

Bio Pharma Dive

DECEMBER 8, 2020

Agency staff didn't raise any red flags in their review of the companies' study results, documents released ahead of a key advisory committee meeting Thursday show.

Scientist 253

Scientist Vaccination Vaccine 253

pharmaphorum

DECEMBER 17, 2020

Tik Tok is unlikely to spring to mind as a source of reliable information about complex issues, but scientists are using it to fly the flag for COVID-19 vaccines and other health topics. When we talk about vaccines as health professionals, people who are vehemently anti-vaccine can take it out of context for their agenda.

Scientist 97

Scientist Vaccination Vaccine Medicine 97

AuroBlog - Aurous Healthcare Clinical Trials blog

DECEMBER 14, 2022

The Department of Biotechnology (DBT) is extending support to the institutions and scientists to set up Centres of Excellence in the country for nano-vaccines and nano-adjuvants, to treat cancer and other diseases.The Department has invited Letters of Intent (LoIs) for ‘Setting up of CoE in Nano-Vaccines & Nano-Adjuvants’ for a period of five years (..)

Vaccination 151

Vaccination Vaccine Development Scientist 151

Drug Discovery World

SEPTEMBER 19, 2023

The University of Oxford has revealed that researchers are currently in the advanced stages of preparing for a clinical trial of a Nipah vaccine using the ChAdOx1 vector. There are currently no approved vaccines or treatments for Nipah virus infection. Seasonal outbreaks have occurred annually in Bangladesh since 2001.

Clinical Trials 64

Clinical Trials Clinical Trials Scientist Trials 64

Intouch Solutions

JANUARY 19, 2021

Now, it's worth taking a moment to applaud the superhuman accomplishments of vaccine scientists worldwide. The post Hats Off to Vaccine Scientists, Even as Distribution Lags appeared first on Intouch Solutions. Soon enough, COVID-19 will be the stuff of blockbusters and bestsellers, full of cliffhangers and drama.

Scientist 64

Scientist Vaccination Vaccine Marketing 64

Medical Xpress

FEBRUARY 28, 2023

A team of scientists from Scripps Research and the University of North Carolina (UNC) has found antibodies in the blood of certain COVID-19 donors that can block infection from a broad set of coronaviruses—specifically, in people who have recovered from the virus and were then vaccinated.

Scientist 119

Scientist Antibody Vaccination Vaccine 119

Medical Xpress

FEBRUARY 9, 2023

To combat the fentanyl epidemic in the United States, researchers at the University of Houston have created a fentanyl vaccine that could help prevent overdoses. They aim to test the vaccine in a human trial within the next year.

Vaccination 73

Vaccination Vaccine Scientist Trials 73

STAT News

NOVEMBER 16, 2022

BOSTON — Even after leading the charge combating the worst pandemic in a century, vaccine researcher Kathrin Jansen doesn’t feel that she can relax. Another pandemic — this one based on an influenza virus — is inevitable, Jansen said at the annual STAT Summit on Tuesday. Read the rest…

Vaccination 105

Vaccination Vaccine Scientist Research 105

Medical Xpress

NOVEMBER 24, 2022

An experimental mRNA-based vaccine against all 20 known subtypes of influenza virus has provided broad protection from otherwise lethal flu strains in initial tests, and thus might serve one day as a general preventative measure against future flu pandemics, according to researchers from the Perelman School of Medicine at the University of Pennsylvania. (..)

Vaccination 119

Vaccination Vaccine Scientist Development 119

BioPharma Reporter

DECEMBER 23, 2020

People who have been infected with SARS-CoV-2 retain immune memory to protect against reinfection for 'at least eight months', according to Australian scientists. This research is the strongest evidence for the likelihood that vaccines against the virus will work for long periods," they say.

Scientist 105

Scientist Vaccination Vaccine Research 105

NPR Health - Shots

NOVEMBER 4, 2022

Vaccines went to the rich world while Africa lacks access. African scientists call for a bold plan to protect against pathogens. Monkeypox is the latest case of how global health inequities persist. Image credit: Tommy Trenchard for NPR)

Scientist 105

Scientist Vaccination Vaccine 105

NY Times

NOVEMBER 28, 2021

A “Frankenstein mix” of mutations raises concerns, but the variant may remain vulnerable to current vaccines. If not, revisions will be necessary.

Vaccination 110

Vaccination Vaccine Scientist Drugs 110

Drug Discovery World

APRIL 18, 2024

For the first time, a controlled human infection model for tuberculosis (TB) has been developed and could help with the future development of TB vaccines. The team states that it’s the first step towards establishing a challenge model that can be used to test new vaccines for TB.

Vaccination 52

Vaccination Vaccine Development Bacterium 52

XTalks

FEBRUARY 19, 2024

Moderna has been testing an experimental mRNA vaccine aimed at combating the human cytomegalovirus (CMV), which poses significant health risks to newborns and immunocompromised patients. The team used the data and patient samples from a gB/MF59 Phase II trial in adolescent girls as a benchmark to assess the new mRNA-based vaccine.

Vaccination 59

Vaccination Vaccine Trials Clinical Trials 59

Medical Xpress

MAY 6, 2023

For 60 years, doctors and scientists searched for a vaccine against a common virus that, while sometimes deadly, is little known to the public. The hunt is over.

Vaccination 103

Vaccination Vaccine Doctors Doctor 103

Scienmag

OCTOBER 12, 2020

Credit: WEI Wei Exploration of new leukemia antigens and construction of appropriate delivery systems using FDA-approved material are important strategies for developing leukemia vaccines for clinic use.

Vaccination 93

Vaccination Vaccine Development Scientist 93

Medical Xpress

DECEMBER 7, 2022

There's even more reason to think a vaccine developed against smallpox can help the body fight against mpox (monkeypox virus disease) as well, according to researchers at La Jolla Institute for Immunology (LJI).

Vaccination 76

Vaccination Vaccine Scientist Branding 76

Scienmag

SEPTEMBER 24, 2021

Scientists at Stanford University and the University of North Carolina at Chapel Hill have created a 3D-printed vaccine patch that provides greater protection than a typical vaccine shot. Scientists at Stanford University and the University of North Carolina at […]. CHAPEL HILL, N.C.

Vaccination 78

Vaccination Vaccine Scientist 78

Scienmag

DECEMBER 27, 2021

An international team of scientists have identified antibodies that neutralize omicron and other SARS-CoV-2 variants. By identifying the targets of these “broadly neutralizing” antibodies on the spike protein, it might be possible to design vaccines and antibody treatments […].

Antibody 73

Antibody Scientist Protein Vaccination 73